{
    "clinical_study": {
        "@rank": "19865", 
        "acronym": "OPRA", 
        "arm_group": {
            "arm_group_label": "Implant System", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "Patients with transfemoral amputations (TFA) frequently experience problems related to the\n      use of socket-suspended prostheses 1-3. These problems increase with short or deformed\n      stumps 4. The potential for improvement is substantial. Based on the very good long-term\n      results with osseointegrated titanium implants for edentulous patients 5, osseointegrated\n      hearing aids 6, cranio-facial prostheses 7 and prostheses for thumb-amputated patients 8,\n      the clinical development of osseointegrated prostheses for TFA started in 1990, in\n      Gothenburg, Sweden. The concept has gradually been modified and improved. In 1999, a\n      prospective clinical trial began.\n\n      The hypothesis is that the treatment will improve quality of life."
        }, 
        "brief_title": "Osseointegrated Prostheses for the Rehabilitation of Amputees", 
        "completion_date": {
            "#text": "May 2027", 
            "@type": "Anticipated"
        }, 
        "condition": "Transfemoral Amputation", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Transfemoral amputation\n\n        Exclusion Criteria:\n\n          -  Transfemoral amputation due to vascular disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "51", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 15, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01725711", 
            "org_study_id": "R402-98"
        }, 
        "intervention": {
            "arm_group_label": "Implant System", 
            "intervention_name": "OPRA Implant System", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 13, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Gothenburg", 
                    "country": "Sweden", 
                    "state": "VG", 
                    "zip": "413 45"
                }, 
                "name": "Sahlgrenska University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "1", 
        "official_title": "Osseointegrated Prostheses for the Rehabilitation of Amputees.", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "Sweden: The National Board of Health and Welfare", 
                "Sweden: Medical Products Agency"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2027", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary efficacy variable is the change in Q-TFA Prosthetic Use Score as compared baseline.", 
            "measure": "Q-TFA Prosthetic Use Score", 
            "safety_issue": "No", 
            "time_frame": "0,1,2,3,5,7,10,15,20 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01725711"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Integrum", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Sahlgrenska University Hospital, Sweden", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "G\u00f6teborg University", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Integrum", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 1999", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2012"
    }
}